I’d like to thank the FDA for admitting they’ve messed up; for admitting they’ve not kept the general public’s best interest at heart.
It appears as if monitoring various doctors financial interests when performing clinical trails wasn’t at the top of the FDA’s priority list. Essentially, if Merck wanted a drug out there, the doctors performing the clinical trials would be tied to Merck somehow. Joy.
Many, including myself, have always thought some drugs weren’t tested enough, clinical trials were too short, and that there were other motives for some of these dangerous drugs to be ‘approved’ by the FDA. Just in the last few years, we could name a few top selling drugs that have had to be pulled off the shelves because they were too dangerous. Unfortunately, people had to die or get very sick before these drugs were taken off the market.
Perhaps what should happen now, since the FDA has admitted their failure to decrease bias in clinical studies, is that the government needs to take a closer look at how the FDA is run and how it manages clinical trials. It is very unfortunate that money takes precedence over the value of life.
